1. Home
  2. MBBC vs RNXT Comparison

MBBC vs RNXT Comparison

Compare MBBC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$11.64

Market Cap

33.5M

Sector

Finance

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

N/A

Current Price

$0.88

Market Cap

36.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBBC
RNXT
Founded
1902
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
36.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MBBC
RNXT
Price
$11.64
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.75
AVG Volume (30 Days)
7.4K
214.1K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$7,299,708.00
$928,000.00
Revenue This Year
N/A
$2,795.35
Revenue Next Year
N/A
$272.69
P/E Ratio
$101.88
N/A
Revenue Growth
7.77
N/A
52 Week Low
$8.74
$0.70
52 Week High
$12.89
$1.69

Technical Indicators

Market Signals
Indicator
MBBC
RNXT
Relative Strength Index (RSI) 57.56 44.91
Support Level $11.21 $0.83
Resistance Level $11.99 $1.00
Average True Range (ATR) 0.29 0.06
MACD 0.03 0.01
Stochastic Oscillator 63.92 36.53

Price Performance

Historical Comparison
MBBC
RNXT

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: